SBH
ASXC

Segall Bryant & Hamill’s Asensus Surgical, Inc. ASXC Stock Holding History

Segall Bryant & Hamill’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,000
Closed -$19K – 591
2017
Q3 		$19K Sell
1,000
-346
-26% -$4.03K ﹤0.01% 566
2017
Q2 		$12K Hold
1,346
– – ﹤0.01% 553
2017
Q1 		$21K Hold
1,346
– – ﹤0.01% 545
2016
Q4 		$23K Hold
1,346
– – ﹤0.01% 536
2016
Q3 		$30K Hold
1,346
– – ﹤0.01% 546
2016
Q2 		$21K Buy
1,346
+577
+75% +$18.1K ﹤0.01% 543
2016
Q1 		$42K Sell
769
-423
-35% -$18.1K ﹤0.01% 542
2015
Q4 		$38K Hold
1,192
– – ﹤0.01% 528
2015
Q3 		$35K Hold
1,192
– – ﹤0.01% 538
2015
Q2 		$46K Buy
+1,192
New +$54.9K ﹤0.01% 549

Other funds holding ASXC

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Segall Bryant & Hamill's ASXC Position: Q4 2017 in Review

Segall Bryant & Hamill sold out of Asensus Surgical, Inc. (ASXC) in Q4 2017, closing a stake of 1,000 shares — an estimated $19K sold.

Segall Bryant & Hamill first reported a position in ASXC in Q2 2015 and held it in 10 quarters. The position peaked at $46K in Q2 2015. 85 funds tracked by Wall St. Rank hold ASXC as of Q4 2017.

  • Segall Bryant & Hamill reported no remaining Asensus Surgical, Inc. position as of Q4 2017 after selling out during the quarter.
  • Segall Bryant & Hamill sold 1,000 Asensus Surgical, Inc. shares in Q4 2017, an estimated $19K.
  • Segall Bryant & Hamill first reported a position in Asensus Surgical, Inc. in Q2 2015 and held it in 10 quarters.
  • Segall Bryant & Hamill's Asensus Surgical, Inc. position peaked at $46K in Q2 2015.
  • 85 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2017.

Based on Segall Bryant & Hamill's 13F filing for Q4 2017, filed 15 Feb 2018.